Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid CB1 receptor agonists

Details for Australian Patent Application No. 2004298782 (hide)

Owner N.V. Organon

Inventors Adam-Worrall, Julia

Agent Spruson & Ferguson

Pub. Number AU-B-2004298782

PCT Pub. Number WO2005/058327

Priority 60/530,528 17.12.03 US; 03104768.1 17.12.03 EP

Filing date 13 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 17 June 2010

International Classifications

C07D 471/06 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 498/16 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/058327 Priority application(s): WO2005/058327

2 November 2006 Assignment before Grant

  Akzo Nobel N.V. The application has been assigned to N.V. Organon

17 June 2010 Application Accepted

  Published as AU-B-2004298782

14 October 2010 Standard Patent Sealed

22 December 2011 Alteration of Name

  The name of the patentee has been altered to MSD Oss B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298784-3-cyano-quinoline derivatives with antiproliferative activity

2004298781-Stabilized interferon liquid formulations